Results 31 to 40 of about 7,985,327 (252)
Neoadjuvant Chemotherapy in Luminal A Breast Carcinoma: Histopathological Evidence of Limited Impact
Introduction. Breast cancer is the most frequently diagnosed malignancy among women worldwide, including in Saudi Arabia. Aim of work: This retrospective study evaluated the histopathological alterations in luminal A breast carcinomas following ...
Elham Saad +6 more
doaj +1 more source
Complete pathological response (ypT0N0M0) after preoperative chemotherapy alone for stage IV rectal cancer [PDF]
Complete pathological response occurs in 10-20% of patients with rectal cancer who are treated with neoadjuvant chemoradiation therapy prior to pelvic surgery.
Theodoros Thomopoulos +15 more
core +2 more sources
ABSTRACT As part of the European Cooperative Study Group for Paediatric Rare Tumours initiative, we developed standard clinical practice guidelines for ovarian sex cord stromal tumors, based on comprehensive national and international cohort analyses, literature review, and a final expert consensus conference.
Dominik T. Schneider +15 more
wiley +1 more source
Comparative Drug Response Profiling in Neuroblastoma Cell Lines and Patient‐Derived Tumor Organoids
ABSTRACT High‐risk neuroblastoma remains a leading cause of pediatric cancer mortality, and improved preclinical models are needed to guide therapeutic developments. We screened seven high‐risk neuroblastoma cell lines and three patient‐derived tumor organoids with 528 compounds alongside bone marrow controls, and compared them with external datasets ...
Krzysztof Wierbiłowicz +12 more
wiley +1 more source
The Role of Magnetic Resonance Imaging in Predicting Pathological Complete Response in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy [PDF]
Objective: Neoadjuvant chemotherapy (NACT) has been used more frequently in the treatment of non-metastatic breast cancer. Achieving a pathological complete response (pCR) after NACT provides us with information about the prognosis of the disease.
Emre Özge +7 more
core +1 more source
Background: Esophageal cancer is the fourth most common cause of cancer-related deaths in India. In 2012, the CROSS trial evaluated the benefit of induction therapy using weekly carboplatin-paclitaxel with 41.4 Gy radiation versus surgery alone ...
Harjot Kaur Bajwa +5 more
doaj +1 more source
Background Management of the node-positive axilla after neoadjuvant chemotherapy is controversial. The aim of this study is to predict the group of patients who may require a less invasive approach for axillary management. One possible group are patients
Mina M. G. Youssef +2 more
doaj +1 more source
Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin +17 more
wiley +1 more source
Objective The efficacy of lymph node ratio (LNR) as a prognostic indicator in locally advanced gastric cancer (LAGC) patients underwent radical resection after neoadjuvant immunochemotherapy (NICT) remains to be demonstrated. The objective of the current
Pei Zhou +7 more
doaj +1 more source
ABSTRACT Pediatric intramedullary low‐grade gliomas (PIMLGGs) are rare neoplasms that present unique clinical and management challenges. Although surgery remains the primary tool for tissue diagnosis and decompression, complete gross‐total resection is frequently unfeasible due to the infiltrative nature of these lesions.
Olga M. Sergeenko +5 more
wiley +1 more source

